FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896799697> ?p ?o ?g. }

• W2896799697 endingPage "1264" @default.
• W2896799697 startingPage "1257" @default.
• W2896799697 abstract "Cutaneous melanoma is least common (only about 1% of skin cancers) but is the deadliest malignant tumor. Moreover, amelanotic types of melanoma are very difficult for clinical diagnosis. The standard therapy can cause a lot of side effects, e.g., nausea, vomiting, and headaches, which means that novel and effective strategies are required. Interestingly, phenothiazine derivatives possess sedative, antiemetic, and anticancer activity. Our goal was to determine the effect of perphenazine and prochlorperazine on cell viability, motility, microphthalmia-associated transcription factor (MITF) and tyrosinase content in melanotic and amelanotic melanoma cells. The viability of C32 and COLO829 melanoma cells was evaluated by the WST-1 colorimetric assay; impact on motility of human melanoma was performed by wound-healing assay, while tyrosinase and MITF content were determined by Western blot. In the present study, we explore the anticancer effect of perphenazine and prochlorperazine in human melanotic (COLO829) and amelanotic (C32) melanoma cells concluding that prochlorperazine inhibits cell viability in a concentration-dependent manner, impairs motility, and decreases tyrosinase and MITF amounts. Moreover, the analyzed drugs decrease/increase MITF amount depending on the type of melanoma. We demonstrated that the decrease of MITF and tyrosinase protein induces motility inhibition of C32 cells, which suggests the ability of those drugs to restore cancer cell sensitivity to treatment. The ability of prochlorperazine to contain the spread of the amelanotic melanoma in vivo may be helpful in the development of a new and effective antimelanoma therapies." @default.
• W2896799697 created "2018-10-26" @default.
• W2896799697 creator A5000651997 @default.
• W2896799697 creator A5013111720 @default.
• W2896799697 creator A5050799434 @default.
• W2896799697 date "2019-06-06" @default.
• W2896799697 modified "2023-10-15" @default.
• W2896799697 title "Antimelanoma activity of perphenazine and prochlorperazine in human COLO829 and C32 cell lines" @default.
• W2896799697 cites W1966369019 @default.
• W2896799697 cites W1980459902 @default.
• W2896799697 cites W1986210161 @default.
• W2896799697 cites W1991995655 @default.
• W2896799697 cites W2008151555 @default.
• W2896799697 cites W201163518 @default.
• W2896799697 cites W2022793947 @default.
• W2896799697 cites W2034513172 @default.
• W2896799697 cites W2036225240 @default.
• W2896799697 cites W2038187853 @default.
• W2896799697 cites W2051457501 @default.
• W2896799697 cites W2051807533 @default.
• W2896799697 cites W205529717 @default.
• W2896799697 cites W2058421384 @default.
• W2896799697 cites W2061591128 @default.
• W2896799697 cites W2066717393 @default.
• W2896799697 cites W2075240818 @default.
• W2896799697 cites W2102927263 @default.
• W2896799697 cites W2166758638 @default.
• W2896799697 cites W2314312008 @default.
• W2896799697 cites W2336247535 @default.
• W2896799697 cites W2574813995 @default.
• W2896799697 cites W2592824004 @default.
• W2896799697 cites W2611218544 @default.
• W2896799697 cites W2613372899 @default.
• W2896799697 cites W2735235713 @default.
• W2896799697 cites W2751035971 @default.
• W2896799697 cites W2772807130 @default.
• W2896799697 cites W2781525129 @default.
• W2896799697 cites W2791672440 @default.
• W2896799697 cites W2915478882 @default.
• W2896799697 cites W2974836652 @default.
• W2896799697 cites W2995083238 @default.
• W2896799697 cites W3017900405 @default.
• W2896799697 cites W3024125254 @default.
• W2896799697 doi "https://doi.org/10.1007/s00210-019-01668-5" @default.
• W2896799697 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31172223" @default.
• W2896799697 hasPublicationYear "2019" @default.
• W2896799697 type Work @default.
• W2896799697 sameAs 2896799697 @default.
• W2896799697 citedByCount "8" @default.
• W2896799697 countsByYear W28967996972020 @default.
• W2896799697 countsByYear W28967996972021 @default.
• W2896799697 countsByYear W28967996972022 @default.
• W2896799697 crossrefType "journal-article" @default.
• W2896799697 hasAuthorship W2896799697A5000651997 @default.
• W2896799697 hasAuthorship W2896799697A5013111720 @default.
• W2896799697 hasAuthorship W2896799697A5050799434 @default.
• W2896799697 hasBestOaLocation W28967996971 @default.
• W2896799697 hasConcept C107538193 @default.
• W2896799697 hasConcept C1491633281 @default.
• W2896799697 hasConcept C177504595 @default.
• W2896799697 hasConcept C181199279 @default.
• W2896799697 hasConcept C185592680 @default.
• W2896799697 hasConcept C2777658100 @default.
• W2896799697 hasConcept C502942594 @default.
• W2896799697 hasConcept C53227056 @default.
• W2896799697 hasConcept C55493867 @default.
• W2896799697 hasConcept C58207958 @default.
• W2896799697 hasConcept C71924100 @default.
• W2896799697 hasConcept C86803240 @default.
• W2896799697 hasConcept C87554066 @default.
• W2896799697 hasConcept C95444343 @default.
• W2896799697 hasConcept C98274493 @default.
• W2896799697 hasConceptScore W2896799697C107538193 @default.
• W2896799697 hasConceptScore W2896799697C1491633281 @default.
• W2896799697 hasConceptScore W2896799697C177504595 @default.
• W2896799697 hasConceptScore W2896799697C181199279 @default.
• W2896799697 hasConceptScore W2896799697C185592680 @default.
• W2896799697 hasConceptScore W2896799697C2777658100 @default.
• W2896799697 hasConceptScore W2896799697C502942594 @default.
• W2896799697 hasConceptScore W2896799697C53227056 @default.
• W2896799697 hasConceptScore W2896799697C55493867 @default.
• W2896799697 hasConceptScore W2896799697C58207958 @default.
• W2896799697 hasConceptScore W2896799697C71924100 @default.
• W2896799697 hasConceptScore W2896799697C86803240 @default.
• W2896799697 hasConceptScore W2896799697C87554066 @default.
• W2896799697 hasConceptScore W2896799697C95444343 @default.
• W2896799697 hasConceptScore W2896799697C98274493 @default.
• W2896799697 hasFunder F4320310064 @default.
• W2896799697 hasIssue "10" @default.
• W2896799697 hasLocation W28967996971 @default.
• W2896799697 hasLocation W28967996972 @default.
• W2896799697 hasOpenAccess W2896799697 @default.
• W2896799697 hasPrimaryLocation W28967996971 @default.
• W2896799697 hasRelatedWork W1180754862 @default.
• W2896799697 hasRelatedWork W2001405358 @default.
• W2896799697 hasRelatedWork W2031841201 @default.
• W2896799697 hasRelatedWork W2051655321 @default.
• W2896799697 hasRelatedWork W2362510634 @default.

• next